Quick Answer
MAXCYTE, INC. reported Operating Income of -$51.90 million for fiscal year 2025.
MAXCYTE, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$51.90M | -1.4% |
| 2024 | -$51.20M | -6.0% |
| 2023 | -$48.30M | -76.5% |
| 2022 | -$27.36M | -50.4% |
| 2021 | -$18.19M | -64.5% |
| 2020 | -$11.06M | +11.0% |
| 2019 | -$12.42M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$14.15M | -0.7% | +0.5% |
| June 30, 2025 | -$14.23M | -18.9% | -15.7% |
| March 31, 2025 | -$12.29M | -0.2% | +12.5% |
| September 30, 2024 | -$14.05M | -0.7% | -17.4% |
| June 30, 2024 | -$11.97M | +8.5% | +2.5% |
| March 31, 2024 | -$12.28M | +6.9% | +12.0% |
| September 30, 2023 | -$13.95M | -80.9% | -6.7% |
| June 30, 2023 | -$13.07M | -49.6% | +0.8% |
- MAXCYTE, INC. showed a decrease of -1.4% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, MAXCYTE, INC.’s operating income has declined by 317.9% (from -$12.42 million to -$51.90 million).
- The most recent figure is from MAXCYTE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: